Viewing StudyNCT00063479



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00063479
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2003-06-27

Brief Title: Bisphosphonate Treatment of Osteogenesis Imperfecta
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Osteogenesis Imperfecta
Keywords:
Name View
pamidronate View
Osteogenesis Imperfecta View
OI View
bone markers View
fracture View
bone loss View
pediatric View
bisphosphonate View
brittle bone disease View